Becton Dickinson (BDX) PT Lowered to $280 at Raymond James Following FDA Letter
Tweet Send to a Friend
Raymond James analyst Lawrence Keusch lowered the price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
